How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and ...

Jabil (JBL) closed the most recent trading day at $167.32, moving +0.48% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.03%. Meanwhile, the Dow gained 0.28%, and ...

Shares of Jabil Inc. (NYSE:JBL – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. Two investment ...

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer ...

Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...

The deal complements Jabil’s specialty in injectable drug delivery systems, like those used for popular GLP-1 diabetes drugs ...

Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Jabil (NYSE:JBL – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday. JBL has been the subject of ...